Healthcare
Live Price
Offline$5.87
-2.65% today
Window Change
-13.64%
Window
Oct 8, 2025 → Jun 12, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 171 bars · Oct 8, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Turn Therapeutics Inc. (TTRX) is a Healthcare stock with a market cap of $110.00M and listed on NASDAQ. The stock last traded around $5.87 and down 13.6% across the available one-year price window (Oct 8, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -76.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -76.9%, free cash flow -85.9% with operating margin 0.0% and ROIC -94.4%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TTRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TTRX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TTRX Max Drawdown
-70.54%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TTRX and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.